Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Vinorelbine-cisplatin confirmed superior in stage II-IIIA NSCLC / News in Context

Feb. 20, 2007

Ariad plans IND for AP-24534 for CML

Feb. 19, 2007

Ariad advances phase III plans for AP-23573

Feb. 19, 2007

Rh-Apo2L begins phase II trials in China

Feb. 19, 2007

Promising antitumor activity of combined therapy with docetaxel and the GHRH antagonist JMR-132

Feb. 19, 2007

Satraplatin NDA filing completed

Feb. 16, 2007

Teverelix LA has same effect on testosterone suppression in normal and obese subjects

Feb. 16, 2007

IPI-504 studied for NSCLC

Feb. 16, 2007

Treatment under way in phase II study of Litx therapy in glioma

Feb. 16, 2007

Poniard seeks to begin clinical testing of oral picoplatin

Feb. 15, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...